Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures
NEJM 368:2113-2124, Baron, T.,et al, 2013
Post-acute care and secondary prevention after ischaemic stroke
BMJ 342:d2083, McArthur, K.S.,et al, 2011
Venous and arterial thrombo-embolic complications of hormonal treatment in a male-to-female transgender patient
J Clin Neurosci 15:714-716, Mullins, G.M.,et al, 2008
Management of Antiphospholipid Antibody Syndrome, A Systematic Review
JAMA 295:1050-1057, Lim,W.,et al, 2006
Low-Molecular-Weight Heparins or Heparinoids Versus Standard Unfarctionated Heparin for Acute Ischemic Stroke (Cochrane Review)
Stroke 33:1925-1926, Counsell,C. &Sandercock,P., 2002
Factor V Leiden Mutation in a Case with Ischemic Stroke: Which Relationship?
Angiology 49:79-82, Orlandi, G.,et al, 1998
Atrial Fibrillation as a Risk Factor for Deep Venous Thrombosis and Pulmonary Emboli in Stroke Patients
Stroke 22:760-762, Noel,P.,et al, 1991
Acute Cerebrovascular Episodes in Systemic Lupus Erythematosus
Quart J Med 293:739-750, Eustace,S.,et al, 1991
Nonbacterial Thrombotic Endocarditis
Arch Neurol 39:95-98, Biller,J.,et al, 1982
Superior Sagittal Sinus Thrombosis
Arch Neurol 34:2, Gettelfinger,D.M.,et al, 1977
Cerebral Embolism Caused by Nonbacterial Thrombotic Endocarditis
Neurol 10:391, Barron,K.D.,et al, 1960